Regenerative Medicine, Stem Cell Injections and HipTrac

Independent - Easy - Effective

Currently there are more than 30 million individuals in the United States suffering from Hip Osteoarthritis (OA) and other hip joint pathologies. Most individuals will develop joint capsule restrictions at their hip that will create abnormal biomechanics around their hip, knee, lumbar spine and pelvis. As the capsule progressively tightens, intra-articular pressure increases thereby creating more pain for the individual as well as decreased mobility, function and quality of life.

The use of Regenerative Medicine and Stem Cell injections has shown tremendous potential in the treatment of hip pain and OA through tissue healing and functional repair. During both the pre-habilitation and rehabilitation phases of regenerative medicine therapy, it’s critical to optimize the patient’s joint capsule mobility and increase tolerance for movement and exercise. Without specifically improving capsule mobility, the patient will continue demonstrating poor movement patterns leading to increased pain, non-compliance and oftentimes less-positive results overall.

HipTrac^TM is an FDA-cleared medical device that replicates the most widely-used, manual joint capsule mobilization technique by health care providers called Long Axis Traction (LAT). LAT increases mobility, decreases pain and improves the individuals tolerance for exercise. Traction has also shown improvements in cellular biology of articular cartilage leading to tissue repair and mechanical resilience.

Combining independent, easy-to-use, and effective hip traction with regenerative medicine injections and exercise shows great promise in the treatment of hip OA. Learn about the science behind HipTrac here, more details about use here and see testimonials here.